Nanjing Chest Hospital

Nanjing, Jiangsu 210029

1 studies enrolling now · 4 studies all time

What they study most

Advanced Lung Cancer, Extensive-Stage Small-Cell Lung Cancer, Limited Stage Small Cell Lung Cancer, NSCLC, Non-small Cell Lung Cancer, Small-Cell Lung Cancer

Studies at this site

• A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer — Recruiting now
• A Study of Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung Cancer — Stopped early
• Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab — Running, not enrolling
• Study of Ociperlimab Plus Tislelizumab Plus Chemoradiotherapy in Participants With Untreated Limited-Stage Small Cell Lung Cancer — Completed